Lv41
450 积分 2023-08-22 加入
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
20天前
已完结
CAR-T therapy in solid tumors
20天前
已完结
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy
20天前
已完结
From molecular design to clinical translation: dual-targeted CAR-T strategies in cancer immunotherapy
20天前
已完结
Multidimensional analysis reveals predictive markers for CAR-T efficacy
20天前
已完结
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies
26天前
已完结
A Comparative Study of Bayesian Optimal Interval (BOIN) Design With Interval 3 + 3 (i3 + 3) Design for Phase I Oncology Dose-Finding Trials
26天前
已完结
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
6个月前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
8个月前
已完结
Immune control of brain physiology
8个月前
已完结
皖公网安备34019202002308
